Medical Oncology

Neuromuscular

Questions discussed in this category

What treatments, after appropriate dose reductions/delays, do you offer for patients with oxaliplatin-induced cold allodynia/dysesthesia?

Do medications that help with painful chemotherapy-induced sensory neuropathy also help with the cold neuropathy?

3 Answers available

What are outpatient strategies to mitigate taxane-induced peripheral neuropathy?

Are there any protocols in place? Aside from telling patients to use ice packs or bags or immerse hands/feet in ice water baths from 15" before to 15"...

3 Answers available

How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?

Can you elaborate on reasons for a non-quantifiable SPEP and how does one follow the paraprotein?

3 Answers available

How do you manage immunotherapy-induced myasthenia gravis?

2 Answers available

How would you approach evaluation and treatment of a patient on pembrolizumab therapy who presents with symmetric, proximal, upper extremity and lower extremity painful weakness without an elevated CK?

1 Answer available

Papers discussed in this category

Sports medicine (Auckland, N.Z.), 2021 Dec 29

Exercise and Neuropathy: Systematic Review with Meta-Analysis.

JAMA internal medicine, 2024 Sep 01

Preventive Effect of Neuromuscular Training on Chemotherapy-Induced Neuropathy: A Randomized Clinical Trial.

Cureus, 2022 Oct 24

Myasthenia Gravis in the Setting of Immune Checkpoint Inhibitor Therapy: Practical Considerations and Opinion-Based Approach to Acute Management.

ESMO open, 2023 Apr 03

A randomized controlled trial of hand/foot-cooling by hilotherapy to prevent oxaliplatin-related peripheral neuropathy in patients with malignancies of the digestive system.

JAMA, 2013-04-03

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

Annals of oncology : official journal of the European Society for Medical Oncology, 2014-06

Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT.

J. Clin. Oncol.,

OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study.

J Clin Oncol, 2020 Jul 14

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025 Mar 25

Core preoperative symptoms and patients' symptom experiences in oral cancer: a mixed-methods study.

Pain, 2020 Feb

Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2014 Jan 01

Prevention and treatment of chemotherapy-induced peripheral neuropathy.

Medical Oncology

Neuromuscular

Questions discussed in this category

Papers discussed in this category

Related Topics in Medical Oncology